- Home
- PNI vs ZYXI Comparison
PNI vs ZYXI Comparison
Compare PNI & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- ZYXI
- Stock Information
- Founded
- PNI 2002
- ZYXI 1996
- Country
- PNI United States
- ZYXI United States
- Employees
- PNI N/A
- ZYXI N/A
- Industry
- PNI Trusts Except Educational Religious and Charitable
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PNI Finance
- ZYXI Health Care
- Exchange
- PNI Nasdaq
- ZYXI Nasdaq
- Market Cap
- PNI 82.7M
- ZYXI 66.5M
- IPO Year
- PNI N/A
- ZYXI N/A
- Fundamental
- Price
- PNI $6.87
- ZYXI $2.07
- Analyst Decision
- PNI
- ZYXI Buy
- Analyst Count
- PNI 0
- ZYXI 3
- Target Price
- PNI N/A
- ZYXI $6.00
- AVG Volume (30 Days)
- PNI 26.4K
- ZYXI 230.0K
- Earning Date
- PNI 01-01-0001
- ZYXI 04-29-2025
- Dividend Yield
- PNI 4.76%
- ZYXI N/A
- EPS Growth
- PNI N/A
- ZYXI N/A
- EPS
- PNI N/A
- ZYXI N/A
- Revenue
- PNI N/A
- ZYXI $172,401,000.00
- Revenue This Year
- PNI N/A
- ZYXI N/A
- Revenue Next Year
- PNI N/A
- ZYXI $23.16
- P/E Ratio
- PNI N/A
- ZYXI N/A
- Revenue Growth
- PNI N/A
- ZYXI N/A
- 52 Week Low
- PNI $6.03
- ZYXI $1.66
- 52 Week High
- PNI $7.89
- ZYXI $11.15
- Technical
- Relative Strength Index (RSI)
- PNI 52.88
- ZYXI 40.51
- Support Level
- PNI $6.70
- ZYXI $1.95
- Resistance Level
- PNI $6.92
- ZYXI $2.19
- Average True Range (ATR)
- PNI 0.09
- ZYXI 0.21
- MACD
- PNI 0.04
- ZYXI 0.08
- Stochastic Oscillator
- PNI 86.11
- ZYXI 45.05
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.